Louise M. Guldbrandt

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC.

Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: A nationwide cohort study of 2127 patients with melanoma, RCC, and NSCLC.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 22, 2026

Quantifying the efficacy-effectiveness gap in first line treatment of metastatic melanoma.

Quantifying the efficacy-effectiveness gap in first line treatment of metastatic melanoma.

Journal: Journal of the National Cancer Institute

Published: March 09, 2026

Real-World Outcomes of Nivolumab and Ipilimumab in Metastatic Melanoma as Third Line and Beyond.

Real-World Outcomes of Nivolumab and Ipilimumab in Metastatic Melanoma as Third Line and Beyond.

Journal: International journal of cancer

Published: January 28, 2026

Safety of tranexamic acid in patients with stage III melanoma undergoing lymph node dissection: a retrospective cohort study.

Safety of tranexamic acid in patients with stage III melanoma undergoing lymph node dissection: a retrospective cohort study.

Journal: Melanoma research

Published: December 22, 2025

Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysis.

Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysis.

Journal: Journal of the National Cancer Institute

Published: June 24, 2025

Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility.

Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility.

Journal: Acta oncologica (Stockholm, Sweden)

Published: November 24, 2024

Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1 - Seasonal variation and association with outcome.

Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1 - Seasonal variation and association with outcome.

Journal: European journal of cancer (Oxford, England : 1990)

Published: June 18, 2024

Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort.

Efficacy of Ipilimumab and Nivolumab in Patients with Melanoma and Brain Metastases-A Danish Real-World Cohort.

Journal: Cancers

Published: May 13, 2024

Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study.

Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study.

Journal: Cancers

Published: October 23, 2021

The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients.

The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients.

Journal: Cancer epidemiology

Published: January 08, 2021

The completeness of chest X-ray procedure codes in the Danish National Patient Registry.

The completeness of chest X-ray procedure codes in the Danish National Patient Registry.

Journal: Clinical epidemiology

Published: March 16, 2017

Development of an algorithm to identify urgent referrals for suspected cancer from the Danish Primary Care Referral Database.

Development of an algorithm to identify urgent referrals for suspected cancer from the Danish Primary Care Referral Database.

Journal: Clinical epidemiology

Published: November 09, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026